A 52-Week Open-Label Extension and Safety Study of Pitavastatin in High-Risk Hyperlipidaemia in Childhood, P/266/2011, P/267/2011, P/268/2011 [EXTENSION OF 700216825].

Trial Profile

A 52-Week Open-Label Extension and Safety Study of Pitavastatin in High-Risk Hyperlipidaemia in Childhood, P/266/2011, P/267/2011, P/268/2011 [EXTENSION OF 700216825].

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Jun 2015

At a glance

  • Drugs Pitavastatin (Primary)
  • Indications Hyperlipidaemia
  • Focus Adverse reactions
  • Acronyms PASCAL 402
  • Sponsors Kowa
  • Most Recent Events

    • 28 Mar 2015 Status changed from recruiting to completed, according to European Clinical Trials Database record.
    • 31 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top